

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive T cell selection (GO:0043368) | 7.06015863 |
| 2 | negative T cell selection (GO:0043383) | 6.53855757 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.20912484 |
| 4 | positive thymic T cell selection (GO:0045059) | 6.14874250 |
| 5 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 5.88873526 |
| 6 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 5.88172107 |
| 7 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 5.82027256 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.78519337 |
| 9 | T cell migration (GO:0072678) | 5.58991148 |
| 10 | respiratory burst (GO:0045730) | 5.00330119 |
| 11 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.91673368 |
| 12 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.91673368 |
| 13 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.88581202 |
| 14 | cellular response to interleukin-15 (GO:0071350) | 4.86923482 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.81702067 |
| 16 | tachykinin receptor signaling pathway (GO:0007217) | 4.77464773 |
| 17 | negative thymic T cell selection (GO:0045060) | 4.68381447 |
| 18 | negative regulation of stress fiber assembly (GO:0051497) | 4.64251131 |
| 19 | thymic T cell selection (GO:0045061) | 4.63587557 |
| 20 | positive regulation of cell killing (GO:0031343) | 4.55434572 |
| 21 | regulation of uterine smooth muscle contraction (GO:0070472) | 4.55254699 |
| 22 | mast cell activation (GO:0045576) | 4.48010664 |
| 23 | T cell selection (GO:0045058) | 4.46940283 |
| 24 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.35801115 |
| 25 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.26524899 |
| 26 | T cell receptor signaling pathway (GO:0050852) | 4.24828367 |
| 27 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.20579325 |
| 28 | positive regulation of hair follicle development (GO:0051798) | 4.19935986 |
| 29 | positive regulation of hair cycle (GO:0042635) | 4.19935986 |
| 30 | interferon-gamma production (GO:0032609) | 4.13970600 |
| 31 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.07907663 |
| 32 | regulation of cell killing (GO:0031341) | 4.06095806 |
| 33 | positive regulation of tolerance induction (GO:0002645) | 4.05948412 |
| 34 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.05245717 |
| 35 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.03236864 |
| 36 | positive regulation of protein homodimerization activity (GO:0090073) | 4.01962652 |
| 37 | positive regulation of T cell cytokine production (GO:0002726) | 3.99320015 |
| 38 | actin nucleation (GO:0045010) | 3.96786007 |
| 39 | T cell mediated immunity (GO:0002456) | 3.95620709 |
| 40 | regulation of gamma-delta T cell activation (GO:0046643) | 3.93879562 |
| 41 | mitochondrial calcium ion transport (GO:0006851) | 3.92558494 |
| 42 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.85813950 |
| 43 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.84377592 |
| 44 | negative regulation of cell killing (GO:0031342) | 3.84377592 |
| 45 | regulation of regulatory T cell differentiation (GO:0045589) | 3.82719736 |
| 46 | cytolysis (GO:0019835) | 3.82252340 |
| 47 | negative regulation of actin filament bundle assembly (GO:0032232) | 3.80202329 |
| 48 | cytidine deamination (GO:0009972) | 3.75627104 |
| 49 | cytidine metabolic process (GO:0046087) | 3.75627104 |
| 50 | cytidine catabolic process (GO:0006216) | 3.75627104 |
| 51 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.74735211 |
| 52 | positive regulation of humoral immune response (GO:0002922) | 3.65894664 |
| 53 | negative regulation of glial cell proliferation (GO:0060253) | 3.65642100 |
| 54 | regulation of T cell tolerance induction (GO:0002664) | 3.64316765 |
| 55 | leukocyte aggregation (GO:0070486) | 3.61150210 |
| 56 | lymphocyte migration (GO:0072676) | 3.60714153 |
| 57 | response to interleukin-15 (GO:0070672) | 3.56209086 |
| 58 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.54571565 |
| 59 | regulation of ruffle assembly (GO:1900027) | 3.54556446 |
| 60 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.53464945 |
| 61 | mast cell degranulation (GO:0043303) | 3.43907822 |
| 62 | mast cell activation involved in immune response (GO:0002279) | 3.43907822 |
| 63 | positive regulation of T cell mediated immunity (GO:0002711) | 3.43012863 |
| 64 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.42918445 |
| 65 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.40870942 |
| 66 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.40644423 |
| 67 | sulfation (GO:0051923) | 3.40182254 |
| 68 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.39877059 |
| 69 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.29487547 |
| 70 | T cell costimulation (GO:0031295) | 3.28551139 |
| 71 | regulation of activation of Janus kinase activity (GO:0010533) | 3.26899327 |
| 72 | lymphocyte costimulation (GO:0031294) | 3.25133017 |
| 73 | natural killer cell activation (GO:0030101) | 3.24742618 |
| 74 | erythrocyte maturation (GO:0043249) | 3.22095420 |
| 75 | regulation of tolerance induction (GO:0002643) | 3.21653928 |
| 76 | DNA deamination (GO:0045006) | 3.21181681 |
| 77 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.20928958 |
| 78 | T cell differentiation (GO:0030217) | 3.20310973 |
| 79 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.19953651 |
| 80 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.17617443 |
| 81 | regulation of calcium-mediated signaling (GO:0050848) | 3.14798211 |
| 82 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.13475905 |
| 83 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.12931052 |
| 84 | ribosomal small subunit assembly (GO:0000028) | 3.11446918 |
| 85 | regulation of T cell mediated immunity (GO:0002709) | 3.03733750 |
| 86 | T cell activation (GO:0042110) | 3.00537120 |
| 87 | positive regulation of leukocyte mediated immunity (GO:0002705) | 2.99069136 |
| 88 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.98654169 |
| 89 | negative regulation of T cell mediated immunity (GO:0002710) | 2.95410828 |
| 90 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.95243805 |
| 91 | sequestering of actin monomers (GO:0042989) | 2.90001494 |
| 92 | erythrocyte development (GO:0048821) | 2.88537851 |
| 93 | regulation of defense response to virus by virus (GO:0050690) | 2.87929418 |
| 94 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.86256238 |
| 95 | tolerance induction (GO:0002507) | 2.86016766 |
| 96 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.84897433 |
| 97 | positive regulation of interleukin-4 production (GO:0032753) | 2.84615056 |
| 98 | ATP synthesis coupled proton transport (GO:0015986) | 2.83518463 |
| 99 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.83518463 |
| 100 | positive regulation of fatty acid oxidation (GO:0046321) | 2.82581130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.25275678 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.47037938 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.37548203 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.85882962 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.29618048 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.11647048 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.77789850 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.65676719 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.23595374 |
| 10 | MYB_26560356_Chip-Seq_TH2_Human | 3.02198413 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.88911171 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.88848246 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.75587182 |
| 14 | VDR_22108803_ChIP-Seq_LS180_Human | 2.47544038 |
| 15 | MYB_26560356_Chip-Seq_TH1_Human | 2.32830836 |
| 16 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.20720601 |
| 17 | UTX_26944678_Chip-Seq_JUKART_Human | 2.20537582 |
| 18 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.18922833 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.17458940 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.13092059 |
| 21 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.12387594 |
| 22 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.06669277 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06029341 |
| 24 | GATA3_26560356_Chip-Seq_TH2_Human | 1.99757316 |
| 25 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.89547448 |
| 26 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.86924352 |
| 27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.80160858 |
| 28 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.75238853 |
| 29 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.54057730 |
| 30 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53573717 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50343432 |
| 32 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.48494784 |
| 33 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.44224200 |
| 34 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.36692767 |
| 35 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.27993947 |
| 36 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.26041140 |
| 37 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.25497900 |
| 38 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.25484754 |
| 39 | MAF_26560356_Chip-Seq_TH1_Human | 1.25248233 |
| 40 | MAF_26560356_Chip-Seq_TH2_Human | 1.23632983 |
| 41 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.21696312 |
| 42 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18247822 |
| 43 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.16664312 |
| 44 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.13288271 |
| 45 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.11087144 |
| 46 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.11071232 |
| 47 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.06164912 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.05964740 |
| 49 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.05930987 |
| 50 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.05834367 |
| 51 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.05751348 |
| 52 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.03610301 |
| 53 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.00497623 |
| 54 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99432611 |
| 55 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.98532917 |
| 56 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.98187289 |
| 57 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.94555708 |
| 58 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94367964 |
| 59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.94352835 |
| 60 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.94292350 |
| 61 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.92780166 |
| 62 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91815668 |
| 63 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.90644944 |
| 64 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.89409311 |
| 65 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.89135894 |
| 66 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.87335238 |
| 67 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.86924942 |
| 68 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.85671276 |
| 69 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85410368 |
| 70 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83768831 |
| 71 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.83606912 |
| 72 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82196981 |
| 73 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.81552052 |
| 74 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.81411269 |
| 75 | NCOR_22424771_ChIP-Seq_293T_Human | 0.81368741 |
| 76 | P300_27268052_Chip-Seq_Bcells_Human | 0.81038559 |
| 77 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80144758 |
| 78 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79437785 |
| 79 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.78393847 |
| 80 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78363507 |
| 81 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.77564633 |
| 82 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76728789 |
| 83 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.76430551 |
| 84 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.76264831 |
| 85 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.75177736 |
| 86 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74880149 |
| 87 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.73643292 |
| 88 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.73200360 |
| 89 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.73200360 |
| 90 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.72346787 |
| 91 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.71926095 |
| 92 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.71612166 |
| 93 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.71392275 |
| 94 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.71120650 |
| 95 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.71120650 |
| 96 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.70778935 |
| 97 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.69616924 |
| 98 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.69592154 |
| 99 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.69533031 |
| 100 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.68381520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.60358137 |
| 2 | MP0005451_abnormal_body_composition | 5.31680395 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.39288764 |
| 4 | MP0009785_altered_susceptibility_to | 3.05269454 |
| 5 | MP0003123_paternal_imprinting | 3.02940731 |
| 6 | MP0003787_abnormal_imprinting | 3.02816727 |
| 7 | MP0001800_abnormal_humoral_immune | 2.59162709 |
| 8 | MP0002822_catalepsy | 2.58388892 |
| 9 | MP0003724_increased_susceptibility_to | 2.57475455 |
| 10 | MP0005025_abnormal_response_to | 2.57419125 |
| 11 | MP0009333_abnormal_splenocyte_physiolog | 2.56515841 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.54266855 |
| 13 | MP0005646_abnormal_pituitary_gland | 2.50249845 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.47253425 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.44197020 |
| 16 | MP0001819_abnormal_immune_cell | 2.42231511 |
| 17 | MP0000685_abnormal_immune_system | 2.39006257 |
| 18 | MP0002723_abnormal_immune_serum | 2.27638761 |
| 19 | MP0004947_skin_inflammation | 2.17217849 |
| 20 | MP0000372_irregular_coat_pigmentation | 2.10601090 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.01636034 |
| 22 | MP0005387_immune_system_phenotype | 2.01596337 |
| 23 | MP0001790_abnormal_immune_system | 2.01596337 |
| 24 | MP0008995_early_reproductive_senescence | 1.98726452 |
| 25 | MP0000716_abnormal_immune_system | 1.94573752 |
| 26 | MP0002419_abnormal_innate_immunity | 1.91942926 |
| 27 | MP0005075_abnormal_melanosome_morpholog | 1.90863073 |
| 28 | MP0010155_abnormal_intestine_physiology | 1.85402728 |
| 29 | MP0002398_abnormal_bone_marrow | 1.77575111 |
| 30 | MP0003436_decreased_susceptibility_to | 1.72474998 |
| 31 | MP0002166_altered_tumor_susceptibility | 1.69376553 |
| 32 | MP0003880_abnormal_central_pattern | 1.66088678 |
| 33 | MP0008961_abnormal_basal_metabolism | 1.63597005 |
| 34 | MP0000703_abnormal_thymus_morphology | 1.61265305 |
| 35 | MP0008260_abnormal_autophagy | 1.60966211 |
| 36 | MP0003646_muscle_fatigue | 1.59097964 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.50802825 |
| 38 | MP0009764_decreased_sensitivity_to | 1.47713482 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.47192798 |
| 40 | MP0002405_respiratory_system_inflammati | 1.43172568 |
| 41 | MP0003866_abnormal_defecation | 1.41959774 |
| 42 | MP0002722_abnormal_immune_system | 1.36916555 |
| 43 | MP0002429_abnormal_blood_cell | 1.36675296 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.32791115 |
| 45 | MP0002102_abnormal_ear_morphology | 1.31231246 |
| 46 | MP0005410_abnormal_fertilization | 1.28907610 |
| 47 | MP0005503_abnormal_tendon_morphology | 1.28389155 |
| 48 | MP0005645_abnormal_hypothalamus_physiol | 1.27827557 |
| 49 | MP0004510_myositis | 1.26044493 |
| 50 | MP0001873_stomach_inflammation | 1.25450406 |
| 51 | MP0004381_abnormal_hair_follicle | 1.22217824 |
| 52 | MP0002006_tumorigenesis | 1.20104914 |
| 53 | MP0002933_joint_inflammation | 1.16929618 |
| 54 | MP0001984_abnormal_olfaction | 1.16121990 |
| 55 | MP0008469_abnormal_protein_level | 1.15614567 |
| 56 | MP0001533_abnormal_skeleton_physiology | 1.14344245 |
| 57 | MP0008789_abnormal_olfactory_epithelium | 1.12752014 |
| 58 | MP0001919_abnormal_reproductive_system | 1.11045564 |
| 59 | MP0002132_abnormal_respiratory_system | 1.09463772 |
| 60 | MP0001765_abnormal_ion_homeostasis | 1.06247377 |
| 61 | MP0005171_absent_coat_pigmentation | 1.04258064 |
| 62 | MP0009763_increased_sensitivity_to | 1.03950824 |
| 63 | MP0000631_abnormal_neuroendocrine_gland | 0.98675500 |
| 64 | MP0000490_abnormal_crypts_of | 0.96495061 |
| 65 | MP0006072_abnormal_retinal_apoptosis | 0.95159566 |
| 66 | MP0008872_abnormal_physiological_respon | 0.94359001 |
| 67 | MP0003045_fibrosis | 0.92812305 |
| 68 | MP0003806_abnormal_nucleotide_metabolis | 0.92170456 |
| 69 | MP0009840_abnormal_foam_cell | 0.89239134 |
| 70 | MP0000639_abnormal_adrenal_gland | 0.88787168 |
| 71 | MP0008875_abnormal_xenobiotic_pharmacok | 0.85257712 |
| 72 | MP0005636_abnormal_mineral_homeostasis | 0.84026957 |
| 73 | MP0003448_altered_tumor_morphology | 0.81265500 |
| 74 | MP0002736_abnormal_nociception_after | 0.80651347 |
| 75 | MP0009765_abnormal_xenobiotic_induced | 0.79671341 |
| 76 | MP0003075_altered_response_to | 0.78286044 |
| 77 | MP0005464_abnormal_platelet_physiology | 0.77866887 |
| 78 | MP0005389_reproductive_system_phenotype | 0.76935140 |
| 79 | MP0001905_abnormal_dopamine_level | 0.76102118 |
| 80 | MP0000858_altered_metastatic_potential | 0.72559713 |
| 81 | MP0005499_abnormal_olfactory_system | 0.72507004 |
| 82 | MP0005394_taste/olfaction_phenotype | 0.72507004 |
| 83 | MP0004043_abnormal_pH_regulation | 0.71265759 |
| 84 | MP0002234_abnormal_pharynx_morphology | 0.71139836 |
| 85 | MP0000604_amyloidosis | 0.70183652 |
| 86 | MP0003690_abnormal_glial_cell | 0.67179120 |
| 87 | MP0002019_abnormal_tumor_incidence | 0.66955266 |
| 88 | MP0002837_dystrophic_cardiac_calcinosis | 0.66884656 |
| 89 | MP0002735_abnormal_chemical_nociception | 0.66620815 |
| 90 | MP0003950_abnormal_plasma_membrane | 0.66081336 |
| 91 | MP0002693_abnormal_pancreas_physiology | 0.64764839 |
| 92 | MP0002638_abnormal_pupillary_reflex | 0.63001896 |
| 93 | MP0006276_abnormal_autonomic_nervous | 0.59290311 |
| 94 | MP0005390_skeleton_phenotype | 0.54683314 |
| 95 | MP0010329_abnormal_lipoprotein_level | 0.51695865 |
| 96 | MP0002998_abnormal_bone_remodeling | 0.51439953 |
| 97 | MP0005166_decreased_susceptibility_to | 0.50343893 |
| 98 | MP0003279_aneurysm | 0.49588847 |
| 99 | MP0009697_abnormal_copulation | 0.48901356 |
| 100 | MP0001968_abnormal_touch/_nociception | 0.48457827 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IgG deficiency (HP:0004315) | 6.81211260 |
| 2 | T lymphocytopenia (HP:0005403) | 6.19115018 |
| 3 | Increased IgM level (HP:0003496) | 5.67216988 |
| 4 | Abnormality of T cell number (HP:0011839) | 5.21471928 |
| 5 | Severe combined immunodeficiency (HP:0004430) | 5.07380782 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.36609031 |
| 7 | Combined immunodeficiency (HP:0005387) | 4.02124038 |
| 8 | Abnormality of T cells (HP:0002843) | 3.90481865 |
| 9 | Chronic diarrhea (HP:0002028) | 3.79465404 |
| 10 | Thyroiditis (HP:0100646) | 3.76408623 |
| 11 | Diastasis recti (HP:0001540) | 3.53900208 |
| 12 | Acute hepatic failure (HP:0006554) | 3.45262393 |
| 13 | Abnormality of eosinophils (HP:0001879) | 3.44623452 |
| 14 | Autoimmune hemolytic anemia (HP:0001890) | 3.33011425 |
| 15 | Encephalitis (HP:0002383) | 3.31481333 |
| 16 | Increased intramyocellular lipid droplets (HP:0012240) | 3.21077732 |
| 17 | IgM deficiency (HP:0002850) | 3.16870949 |
| 18 | Increased hepatocellular lipid droplets (HP:0006565) | 3.13880482 |
| 19 | Lipid accumulation in hepatocytes (HP:0006561) | 3.01888372 |
| 20 | Recurrent bronchitis (HP:0002837) | 3.00897910 |
| 21 | Thick nail (HP:0001805) | 2.93745004 |
| 22 | Congenital stationary night blindness (HP:0007642) | 2.90654423 |
| 23 | Hypoproteinemia (HP:0003075) | 2.83621659 |
| 24 | Increased muscle lipid content (HP:0009058) | 2.81620862 |
| 25 | Stenosis of the external auditory canal (HP:0000402) | 2.73609750 |
| 26 | Hypergammaglobulinemia (HP:0010702) | 2.72866650 |
| 27 | Pancytopenia (HP:0001876) | 2.72693699 |
| 28 | Abnormality of macrophages (HP:0004311) | 2.72246614 |
| 29 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.71216345 |
| 30 | Hypoplasia of the uterus (HP:0000013) | 2.71107188 |
| 31 | Eosinophilia (HP:0001880) | 2.67765430 |
| 32 | Pustule (HP:0200039) | 2.62933544 |
| 33 | Hyperlipoproteinemia (HP:0010980) | 2.62204681 |
| 34 | 3-Methylglutaconic aciduria (HP:0003535) | 2.61064230 |
| 35 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.59839834 |
| 36 | Chronic otitis media (HP:0000389) | 2.58479375 |
| 37 | Erythema (HP:0010783) | 2.53749824 |
| 38 | Exertional dyspnea (HP:0002875) | 2.46347355 |
| 39 | Leukocytosis (HP:0001974) | 2.41534625 |
| 40 | Cellular immunodeficiency (HP:0005374) | 2.41126639 |
| 41 | Granulocytopenia (HP:0001913) | 2.41117442 |
| 42 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.40903195 |
| 43 | Optic neuritis (HP:0100653) | 2.39087905 |
| 44 | Retrobulbar optic neuritis (HP:0100654) | 2.39087905 |
| 45 | Bronchiectasis (HP:0002110) | 2.38444861 |
| 46 | Brushfield spots (HP:0001088) | 2.37871925 |
| 47 | B lymphocytopenia (HP:0010976) | 2.36579969 |
| 48 | Renal Fanconi syndrome (HP:0001994) | 2.35992195 |
| 49 | Constricted visual fields (HP:0001133) | 2.33049167 |
| 50 | Widely patent fontanelles and sutures (HP:0004492) | 2.32906249 |
| 51 | Amyotrophic lateral sclerosis (HP:0007354) | 2.31095324 |
| 52 | Eczematoid dermatitis (HP:0000976) | 2.29756641 |
| 53 | Myositis (HP:0100614) | 2.27369481 |
| 54 | Hyperglycinuria (HP:0003108) | 2.24764272 |
| 55 | Aplastic anemia (HP:0001915) | 2.24551284 |
| 56 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.23736123 |
| 57 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.23353278 |
| 58 | Lymphopenia (HP:0001888) | 2.21244476 |
| 59 | Septate vagina (HP:0001153) | 2.17572468 |
| 60 | Recurrent otitis media (HP:0000403) | 2.14690104 |
| 61 | Abnormality of B cell number (HP:0010975) | 2.13406203 |
| 62 | Renal cortical cysts (HP:0000803) | 2.09803938 |
| 63 | Hypoplasia of the thymus (HP:0000778) | 2.06158477 |
| 64 | Abnormality of the renal cortex (HP:0011035) | 2.06149556 |
| 65 | Orchitis (HP:0100796) | 2.01159304 |
| 66 | Bronchitis (HP:0012387) | 1.99997115 |
| 67 | Meningitis (HP:0001287) | 1.98922397 |
| 68 | Lymphoma (HP:0002665) | 1.97535562 |
| 69 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.97324450 |
| 70 | Attenuation of retinal blood vessels (HP:0007843) | 1.96850839 |
| 71 | Recurrent fungal infections (HP:0002841) | 1.92870771 |
| 72 | Abnormality of T cell physiology (HP:0011840) | 1.89558329 |
| 73 | Radial bowing (HP:0002986) | 1.89213684 |
| 74 | Redundant skin (HP:0001582) | 1.88216999 |
| 75 | Mediastinal lymphadenopathy (HP:0100721) | 1.87208037 |
| 76 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.85312093 |
| 77 | IgA deficiency (HP:0002720) | 1.85062823 |
| 78 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.84232505 |
| 79 | Agammaglobulinemia (HP:0004432) | 1.83703543 |
| 80 | Alkalosis (HP:0001948) | 1.82843613 |
| 81 | Female pseudohermaphroditism (HP:0010458) | 1.80407129 |
| 82 | Recurrent cutaneous fungal infections (HP:0011370) | 1.80401151 |
| 83 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.80401151 |
| 84 | Cortical visual impairment (HP:0100704) | 1.79597471 |
| 85 | Spontaneous hematomas (HP:0007420) | 1.78958907 |
| 86 | Reticulocytopenia (HP:0001896) | 1.78819088 |
| 87 | Dyschromatopsia (HP:0007641) | 1.78784783 |
| 88 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.78100505 |
| 89 | Abnormality of glycine metabolism (HP:0010895) | 1.78100505 |
| 90 | Hyperphosphaturia (HP:0003109) | 1.77230046 |
| 91 | Conical tooth (HP:0000698) | 1.75097328 |
| 92 | Hypothermia (HP:0002045) | 1.74369706 |
| 93 | Vacuolated lymphocytes (HP:0001922) | 1.73495127 |
| 94 | Stomatitis (HP:0010280) | 1.72567344 |
| 95 | Rectal fistula (HP:0100590) | 1.72404900 |
| 96 | Rectovaginal fistula (HP:0000143) | 1.72404900 |
| 97 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.71966157 |
| 98 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.69092054 |
| 99 | Dicarboxylic aciduria (HP:0003215) | 1.69092054 |
| 100 | Abnormal number of erythroid precursors (HP:0012131) | 1.68574014 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 6.61761657 |
| 2 | ZAK | 5.49955673 |
| 3 | KDR | 4.88466069 |
| 4 | TESK2 | 4.63097208 |
| 5 | SCYL2 | 4.36338667 |
| 6 | TXK | 3.14897776 |
| 7 | TNK2 | 3.13187472 |
| 8 | MAP4K1 | 2.48261594 |
| 9 | TESK1 | 2.47895901 |
| 10 | VRK1 | 2.35914173 |
| 11 | PASK | 2.30591296 |
| 12 | MAP3K10 | 2.01584124 |
| 13 | GRK6 | 1.98011549 |
| 14 | VRK2 | 1.92815550 |
| 15 | PIK3CG | 1.90163846 |
| 16 | ZAP70 | 1.76432898 |
| 17 | LIMK1 | 1.69111778 |
| 18 | ITK | 1.60310935 |
| 19 | TNIK | 1.58145597 |
| 20 | TAOK3 | 1.42068598 |
| 21 | TEC | 1.36630727 |
| 22 | FES | 1.36076854 |
| 23 | SYK | 1.32867427 |
| 24 | CAMKK1 | 1.26281486 |
| 25 | NEK6 | 1.26008052 |
| 26 | ADRBK2 | 1.25649059 |
| 27 | LRRK2 | 1.24366187 |
| 28 | CSK | 1.19246510 |
| 29 | GRK7 | 1.13664119 |
| 30 | BTK | 1.11619428 |
| 31 | NEK9 | 0.98564922 |
| 32 | PIM1 | 0.94575336 |
| 33 | CAMKK2 | 0.91561152 |
| 34 | MAP3K12 | 0.87306149 |
| 35 | MYLK | 0.85660983 |
| 36 | KIT | 0.84256502 |
| 37 | LYN | 0.80230009 |
| 38 | LCK | 0.79476738 |
| 39 | ROCK1 | 0.79291455 |
| 40 | BLK | 0.78968314 |
| 41 | IKBKE | 0.77268417 |
| 42 | TAOK2 | 0.73442532 |
| 43 | CSF1R | 0.68760726 |
| 44 | MAPKAPK3 | 0.68400670 |
| 45 | HCK | 0.67255041 |
| 46 | TRPM7 | 0.60973959 |
| 47 | PKN1 | 0.58640773 |
| 48 | PRKCQ | 0.57862364 |
| 49 | RPS6KA5 | 0.57172267 |
| 50 | MAPK11 | 0.53400029 |
| 51 | MAP3K11 | 0.51077789 |
| 52 | IKBKB | 0.50774695 |
| 53 | GRK1 | 0.50470394 |
| 54 | FRK | 0.48289981 |
| 55 | JAK3 | 0.47865967 |
| 56 | INSRR | 0.47522049 |
| 57 | OBSCN | 0.47259788 |
| 58 | MST4 | 0.47194846 |
| 59 | FYN | 0.46164053 |
| 60 | PINK1 | 0.44266653 |
| 61 | ERBB2 | 0.44049482 |
| 62 | INSR | 0.42239007 |
| 63 | ADRBK1 | 0.42073509 |
| 64 | CDK8 | 0.40796756 |
| 65 | JAK1 | 0.37712908 |
| 66 | IGF1R | 0.35422965 |
| 67 | TYRO3 | 0.33991787 |
| 68 | CDK6 | 0.33777484 |
| 69 | WNK4 | 0.33000813 |
| 70 | RPS6KA4 | 0.31320824 |
| 71 | PRKCA | 0.30456036 |
| 72 | PRKD1 | 0.28478916 |
| 73 | EIF2AK1 | 0.28069013 |
| 74 | ACVR1B | 0.28027067 |
| 75 | ILK | 0.27729338 |
| 76 | MUSK | 0.27283494 |
| 77 | PDGFRB | 0.26401945 |
| 78 | JAK2 | 0.26360001 |
| 79 | CDK4 | 0.25874253 |
| 80 | TBK1 | 0.24379060 |
| 81 | FGFR2 | 0.23612504 |
| 82 | MELK | 0.23431445 |
| 83 | NME1 | 0.23306330 |
| 84 | NTRK2 | 0.21900184 |
| 85 | EGFR | 0.20339620 |
| 86 | MAP4K2 | 0.20033174 |
| 87 | MAP3K13 | 0.17933837 |
| 88 | PAK6 | 0.17457370 |
| 89 | PRKACA | 0.16075960 |
| 90 | PAK1 | 0.15282862 |
| 91 | PTK2B | 0.15168879 |
| 92 | ABL1 | 0.14973121 |
| 93 | CLK1 | 0.14662339 |
| 94 | MAP3K7 | 0.14407341 |
| 95 | PRKCD | 0.14196770 |
| 96 | MAPK15 | 0.13380680 |
| 97 | CSNK1G3 | 0.12545693 |
| 98 | SRC | 0.10631993 |
| 99 | PRKCB | 0.10372154 |
| 100 | RIPK4 | 0.09192110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 7.20079908 |
| 2 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.51054890 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.31789451 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.03816992 |
| 5 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.95055134 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 2.84424206 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 2.54860109 |
| 8 | Malaria_Homo sapiens_hsa05144 | 2.51261899 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.35145248 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.09638109 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 2.07956244 |
| 12 | Measles_Homo sapiens_hsa05162 | 1.88806272 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.82759087 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.75443835 |
| 15 | Shigellosis_Homo sapiens_hsa05131 | 1.68243845 |
| 16 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.61335291 |
| 17 | Allograft rejection_Homo sapiens_hsa05330 | 1.49159998 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.48791753 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.47157270 |
| 20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.46626051 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.44387169 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.42504911 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.41658345 |
| 24 | Alzheimers disease_Homo sapiens_hsa05010 | 1.37130696 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.36163493 |
| 26 | Phototransduction_Homo sapiens_hsa04744 | 1.34035340 |
| 27 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.29661191 |
| 28 | Homologous recombination_Homo sapiens_hsa03440 | 1.25107978 |
| 29 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.21913793 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.21812142 |
| 31 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.20146642 |
| 32 | ABC transporters_Homo sapiens_hsa02010 | 1.16709591 |
| 33 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.15291929 |
| 34 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.12069370 |
| 35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.08493860 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.02517872 |
| 37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.97474398 |
| 38 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.96312933 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86792387 |
| 40 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.86081156 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.82903518 |
| 42 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81331477 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 0.80275096 |
| 44 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.79560049 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79366441 |
| 46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.77349062 |
| 47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.75044855 |
| 48 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.72630879 |
| 49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.71955148 |
| 50 | Huntingtons disease_Homo sapiens_hsa05016 | 0.70057826 |
| 51 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69490503 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.68155872 |
| 53 | Legionellosis_Homo sapiens_hsa05134 | 0.67594099 |
| 54 | RNA polymerase_Homo sapiens_hsa03020 | 0.66525025 |
| 55 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63222841 |
| 56 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.60908847 |
| 57 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.60872720 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.60676483 |
| 59 | Olfactory transduction_Homo sapiens_hsa04740 | 0.58118436 |
| 60 | Mismatch repair_Homo sapiens_hsa03430 | 0.56305426 |
| 61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54367091 |
| 62 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53935018 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53160121 |
| 64 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.51838606 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.51644709 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 0.49466141 |
| 67 | Asthma_Homo sapiens_hsa05310 | 0.49136724 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.47965363 |
| 69 | Tuberculosis_Homo sapiens_hsa05152 | 0.47506938 |
| 70 | Platelet activation_Homo sapiens_hsa04611 | 0.47217810 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46157358 |
| 72 | Taste transduction_Homo sapiens_hsa04742 | 0.45465377 |
| 73 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.44884716 |
| 74 | Apoptosis_Homo sapiens_hsa04210 | 0.44778084 |
| 75 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44377143 |
| 76 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.44365622 |
| 77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41989690 |
| 78 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.41906237 |
| 79 | Leishmaniasis_Homo sapiens_hsa05140 | 0.41631677 |
| 80 | Renin secretion_Homo sapiens_hsa04924 | 0.40283507 |
| 81 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37568688 |
| 82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37460787 |
| 83 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.36604694 |
| 84 | Protein export_Homo sapiens_hsa03060 | 0.36340952 |
| 85 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.35966589 |
| 86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33891028 |
| 87 | Pertussis_Homo sapiens_hsa05133 | 0.33885769 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33475496 |
| 89 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.32105995 |
| 90 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.30475345 |
| 91 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.30467188 |
| 92 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.30261920 |
| 93 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.30183647 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | 0.29744154 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.27249337 |
| 96 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.25612231 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.24202365 |
| 98 | Nicotine addiction_Homo sapiens_hsa05033 | 0.23183538 |
| 99 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.22496521 |
| 100 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.21790273 |

